MDX/Votrient and MDX/Sutent trial expansion

Met with John's Dr. today. We had several questions and he sat with us for some time. While talking about the MDX/Votrient and MDX/Sutent trial, we talked about the promise of early results.

He stated that the trial is being expanded; will probably be in August. This expansion will only take kidney cancer patients who have not yet received treatment. He mentioned specifically papillary and chromophobe in addition to clear cell. He said the success of this trial has made them to want to expand the research to see how many cancer types might benefit from trial.